The same group also showed marked downregulation of BDNF and 5-HT3A, key markers of neuronal excitability and visceral hypersensitivity, while upregulating SERT expression, which is typically reduced in IBS patients (Fig. 1G-1I). The gene discussed is BDNF; the disease is irritable bowel syndrome.